Subscribe to our twitter feeds Subscribe to email digest Subscribe to email alerts

sort by: Most Recent  [   Popular Today  |   Popular This Week  ]
1
announced by Geneseq Biosciences about 1 year , category: Medical & Pharmaceutical, Science
NEW STUDY CONFIRMS CLINICAL UTILITY OF MELASEQ™
0
A new blood test that can diagnose melanoma skin cancers earlier and more accurately has been announced by Melbourne (Australia) based company Geneseq Biosciences.
0
Geneseq Biosciences ('Geneseq') and Australian Clinical Labs ('Clinical Labs') today announced they will partner to bring the first non-invasive melanoma test to market under the trade mark Melaseq™.
0
New research, published today, in PLOS ONE shows that the Melaseq™ blood test can also be used on skin biopsy tissue.